US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Peru Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... appeal in 2015 as thecountry's burden of chronic diseases and demand for medicines grows. A positive economic outlook forPeru in 2016 will also aid in the positive trajectory of the country's pharmaceutical and healthcaremarkets. Headline ...  |  read more...
USD 1,295
Russia Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... government measures, such as the introduction of further price controls,will hurt revenues of innovative and generic drugmakers. Russia will increasingly become a second-tieremerging market (EM) compared to its EM peers, such as China, due to ...  |  read more...
USD 1,295
Turkey Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... migration and the burden of disease in the country. In contrast to European markets wheremanufacturers can expect to achieve higher prices, but with a stagnant growth outlook, Turkey offers stronggrowth potential if drugmakers are able ...  |  read more...
USD 1,295
Ukraine Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... during the yearwill be driven by price inflation rather than actual volume demand growth. Ukrainian consumers will seetheir incomes squeezed from every direction and we expect pharmaceutical market share to shift towardsdomestic drugmakers as imported ...  |  read more...
USD 1,295
Bangladesh Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... and drug exports will be sustained in the years ahead. This favourable outlook is reflected in UKdrugmakerGlaxoSmithKline expected strategies to strengthen its presence in the country. However, currentpolitical tensions in Bangladesh are set to weigh ...  |  read more...
USD 1,295
Finland Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... high-value drugs in the medium-term. However,rising healthcare costs will place a heavy burden on government finances, requiring patented drug makersto prove the cost-effectiveness of their medicines over less expensive generic drugs. Headline Expenditure Projections Pharmaceuticals: ...  |  read more...
USD 1,295
Iran Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... value patented medicines will still be satisfied by multinationals despite increasing competition fromdomestic companies, with the easing of sanctions providing a more attractive operating environment. Headline Expenditure Projections Pharmaceuticals: IRR60,704bn (USD2.35bn) in 2014 to IRR68,851bn ...  |  read more...
USD 1,295
Israel Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... importance in social stability. Headline Expenditure Projections Pharmaceuticals: ILS7.51bn (USD2.10bn) in 2014 to ILS7.82bn (USD2.01bn) in 2015; +4.2% in localcurrency terms and -4.4% in US dollar terms. Healthcare: ILS80.67bn (USD22.55bn) in 2014 to ILS85.80bn (USD22.00bn) ...  |  read more...
USD 1,295
Italy Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... SSN pharmaceutical expenditure will decline in 2015 - creatingfurther revenue pressures for drugmakers as well as pharmacies in Italy and increasing out-of-pocket costsfor the population. In February 2015, it was announced that the public healthcare ...  |  read more...
USD 1,295
Philippines Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... Furthermore, pricing pressures on innovativedrugs continue to intensify as the government seeks to expand universal healthcare coverage while reducinggovernment debt. However, there will be strong opportunities for multinational drugmakers with orphandrug portfolios as a result ...  |  read more...
USD 1,295
Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... oil prices and the Gulf Cooperation Council drug price unificationprocess remaining minimal. Headline Expenditure Projections Pharmaceuticals: SAR28.4bn (USD7.6bn) in 2014 to SAR31.8bn (USD8.5bn) in 2015; +11.9% in bothlocal currency and US dollar terms. Forecast in ...  |  read more...
USD 1,295
Slovakia Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... burden of chronic diseases. With public finances onfirmer footing and a centre-left government promising more generous social spending, multinationaldrugmakers and medical device companies can expect to see growth in revenues from Slovakia. Headline Expenditure Projections ...  |  read more...
USD 1,295
Zimbabwe Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... spending will be driven mainly by importedmedicines with demand owing to a high communicable-disease burden. However, low purchasing power, adeclining economy and ongoing political tensions pose high risk and uncertainty for the market, deterringmultinational drugmakers. ...  |  read more...
USD 1,295
Investigation Report on China Atorvastatin Market, 2010-2019
6/11/2015 | published by: China Research and Intelligence Co., Ltd.
... to reach 160-200 million in the near future. Atorvastatin, a common drug that can lower blood cholesterol levels, was developed by Pfizer under the trade name of Lipitor. Boasting of nearly 20 years of use ...  |  read more...
USD 2,000
Investigation Report on China Octreotide Market, 2010-2019
6/11/2015 | published by: China Research and Intelligence Co., Ltd.
... endocrine tumors. First approved to be sold in 1996, octreotide was developed by Novartis AG under the trade name of Sandostatin. The approved indications at that time were acromegaly, diarrhea and pancreatic cancer. Due to ...  |  read more...
USD 2,000
Cameroon Pharmaceuticals and Healthcare Report Q3 2015
5/20/2015 | published by: BMI Research
... of the industry will continue to bediamond mining with continued investment, both domestic and international, in this segment helping tosupport steady growth in output over our forecast period. While the Angolan government is increasinglyturning its ...  |  read more...
USD 1,295
Jordan Pharmaceuticals and Healthcare Report Q3 2015
5/20/2015 | published by: BMI Research
... of the industry will continue to bediamond mining with continued investment, both domestic and international, in this segment helping tosupport steady growth in output over our forecast period. While the Angolan government is increasinglyturning its ...  |  read more...
USD 1,295
Bulgaria Pharmaceuticals and Healthcare Report Q3 2015
5/27/2015 | published by: BMI Research
... NHIF willleverage its purchasing power to reduce its runaway pharmaceutical expenditure, with negativeimplications for the sector's growth profile. We expect generic drug penetration to rise and patented drugsales to slow considerably as the NHIF rebalances ...  |  read more...
USD 1,295
Lebanon Pharmaceuticals and Healthcare Report Q3 2015
5/27/2015 | published by: BMI Research
... access to healthcarewill drive growth in the pharmaceutical market. Generic drug makers will see strong growth following theimplementation of a unified prescription form, as part of the National Social Security Fund. However,political instability and pressures ...  |  read more...
USD 1,295
Singapore Pharmaceuticals and Healthcare Report Q3 2015
5/27/2015 | published by: BMI Research
... authorities raising itscontribution to the country's total healthcare spending. In addition, Singapore's medical system will beincreasingly geared towards the health needs of the elderly with additional resources in the 2015 budgetchannelled towards the treatment of ...  |  read more...
USD 1,295
Taiwan Pharmaceuticals and Healthcare Report Q3 2015
5/27/2015 | published by: BMI Research
... arefurther reinforced by its high pharmaceutical spending per capita and robust medical infrastructure. Inaddition, Taiwan has a favourable disease profile as the growing burden imposed by chronic diseases willdrive up demand for pharmaceutical products. Headline ...  |  read more...
USD 1,295
Uganda Pharmaceuticals and Healthcare Report Q3 2015
5/27/2015 | published by: BMI Research
... reduction would severely affectthe efforts to stop maternal, new born and child mortality and also access to indispensable health services,the CSOs noted. On a more positive note, the country's economic prospects improved lately as well ...  |  read more...
USD 1,295
Brazil Pharmaceuticals and Healthcare Report Q3 2015
6/3/2015 | published by: BMI Research
... as the demandfor medical provision as well as access to necessary healthcare improves in the country. Limited drugapprovals and the Ministry of Health's implication within the Petrobras scandal will, however, continue togenerate risks within the ...  |  read more...
USD 1,295
Cardiovascular Drugs Markets in China
6/1/2015 | published by: Asia Market Information & Development Company
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic ...  |  read more...
USD 4,000
Bone Morphogenetic Protein (BMP) Receptor Activators -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Receptor Activators. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Bone Morphogenetic Protein (BMP) Receptor Activators Report helps to identify emerging players ...  |  read more...
USD 1,250
  2    4  5  6  7  8  9  10